openPR Logo
Press release

The Microrna Market to Witness Encompassment of Parallel Integration Along With Vertical Integration

The Microrna Market to Witness Encompassment of Parallel

The Microrna Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.

Global microRNA market is expected to witness robust growth during the forecast period. This growth is expected to be primarily driven by increasing demand of microRNA re-agents and kits for various applications that could eventually translate into developing innovative therapeutic solutions for various difficult-to-treat illnesses.

According to the new report published by Persistence Market Research titled, "MicroRNA Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)," which tracks the performance of global microRNA market for the period of eight years, i.e. 2017-2025, the global market is projected to register a CAGR of 7.9% in terms of value during the forecast period. The market is anticipated to be valued at US$ 666.7 Mn by 2025.

Get Sample Copy of this Report@

Company Profiles:

Illumina, Inc.
F. Hoffmann-La Roche Ltd
Agilent Technologies
Bio-Rad Laboratories Inc.
Sigma Aldrich Corp.
Qiagen N.V
Thermo Fisher Scientific, Inc.
HTG Molecular Diagnostics, Inc.
Bioline GmbH (A Meridian Life Science Company)
Rosetta Genomics Ltd.
Dharmacon, a Horizon Discovery Group Co.
BioVendor - Laboratorní medicína a.s.
Miltenyi Biotec
Kaneka Corporation (Eurogentec)
Abcam Plc
GeneCopoeia, Inc.
Promega Corporation
New England Biolabs, Inc.
NanoString Technologies, Inc.
System Biosciences LLC

Request for Methodology@

Global MicroRNA Market: Restraints

Poor reproducibility of research and specificity of products.

The complication in vendor selection due to large product portfolios.

Requirement of skilled personnel and limited availability of data analysis tools.

In-house development of assays for microrna detection.

RNA is more challenging to handle.

High cost associated with microrna reagents and other similar products.

Limited life science research infrastructure in emerging markets.

Global MicroRNA Market: Forecast by Assay Type

On the basis of assay type, the global microRNA market is segmented into PCR-based Assay, miRNA Arrays, Next Generation Sequencing (NGS), and Immunoassay. Immunoassay segment is further segmented into Fluorescent Assays, Colorimetric Assays, and Chemiluminescent Assays.

On the basis of assay type, PCR based arrays segment accounted for 34.9% market share in 2016 in terms of revenue, which is expected to increase to 36.9% by 2025 end. Next generation sequencing is expected to be the second largest segment in terms of revenue growth in microRNA market and is expected to register a CAGR of 8.1% over the forecast period.

Global MicroRNA Market: Forecast by Application

On the basis of application, the global microRNA market is segmented into Clinical Diagnostics and Research. Research is the largest segment in global microRNA market, which is estimated to represent US$ 275.7 Mn, or 76.1% share of the total market in 2017 and US$ 525.6 Mn, or 78.8% by 2025 end, expanding at CAGR of 8.4% over the forecast period.

Research segment dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period. The research segment is expected to be the most lucrative among all end users, with attractiveness index of 1.6.

Access Full Report@

Global MicroRNA Market: Forecast by End User

On the basis of end-user, the global microRNA market is segmented into Academic and Research Institutes, Biopharmaceutical Companies, Contract Research Organizations, and Diagnostic Centers. Academic & research institutes end user is the largest segment in global microRNA market, which is estimated to represent US$ 138.9 Mn of the total market in 2017 and is anticipated to be valued at US$ 255.9 Mn by 2025 end, expanding at CAGR of 7.9% over the forecast period.

Academic & research institutes dominated the global microRNA market in revenue terms in 2016, and the trend is projected to continue throughout the forecast period.

Global MicroRNA Market: Forecast by Region

Five regions have been covered in this report as North America, Latin America, Europe, APAC, and MEA. North America is the largest region in the microRNA market, which is estimated to represent US$ 140.3 Mn, or 38.7% share of the total market in 2017, and is projected to reach US$ 245.9 Mn, or 36.9%, expanding at a CAGR of 7.3% over the forecast period of 2017-2025. Europe is expected to be the second most lucrative market, with an attractiveness index of 1.3 during the forecast period.

Access Related Reports-

Intubation Market:

Growth Factors Market:

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales -

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Microrna Market to Witness Encompassment of Parallel Integration Along With Vertical Integration here

News-ID: 2573110 • Views: 179

More Releases from Persistence Market Research

The Market for Green Data Centres is Predicted to grow Significantly Between 202 …
During the years 2022-2032, the green data centre market is projected to grow significantly at a CAGR of 14.3%. Market analysts expect the green data centre market to increase from US$ 58.6 billion in 2021 to US$ 266.9 billion in 2032. "A significant driver of market expansion is the rising popularity of green data centres among enterprises embracing green initiatives for their regular IT operations to save money." Governments throughout the world
Video Communication Platform as a Service (PaaS) Market
Currently, the global market for video communication platforms as a service is worth US$4.3 billion. By the end of the decade, according to this market study by Persistence Market Research, the valuation will have tripled. The environment is anticipated to undergo significant change and to grow at an astounding CAGR of 48%. A little over 35% of the global market share is accounted for by the North American continent. New Trends
In-Flight Wi-Fi Services Market is Anticipated to Grow at an Outstanding CAGR of …
The market for in-flight Wi-Fi services is expected to generate US$ 5.5 billion in revenue in 2021 and is forecast to grow at an amazing CAGR of around 22% through the end of 2031. The market is expected to have grown by about 7 times from its value in 2021 by the end of 2031. With a striking CAGR of 30% over the following ten years, this market data for in-flight
The Dental Fiberglass Posts Market to look through AI-based genomics at a CAGR o …
New generation wearable technologies are abreast with stress, heart rate, and blood oxygen detectors, thereby letting healthcare professionals to precisely monitor the vital signs, that too, real-time. The current scenario sees an influx of virtual hospital wards as well, wherein centralized communication infrastructure is being used for overseeing numerous patients' treatment, that too at a distance. This is how the Dental Fiberglass Posts Market would behave in the near future. Dental

All 5 Releases

More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event ( opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and